comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 20:17:40 - browse：9286

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Opioid cravings were reduced by anti

knowledge

WSS

Opioid cravings were reduced by anti

What Henrietta Lacks settlement says about racism in medicine

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

In 'major milestone,' FDA approves first cell therapy for solid tumors

TytoCare raises $49 million to build out AI

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

focus

comprehensive

knowledge

Drug repurposing or repositioning? The language matters

Congress may force more Covid

Walensky prepares to leave CDC — and Congress — behind

New study raises questions about niacin and heart health

Sports medicine is finally prioritizing gender equality

Gilgo Beach: Police identify another victim in serial killing investigation

Medicare details structure of new drug price negotiation program

Gilgo Beach: Police identify another victim in serial killing investigation

Hepatitis C has a cure — but many Americans still lack access to it

New study raises questions about niacin and heart health

focus

WATCH: Why do our ears pop?

FDA warns medical device makers about rise in fabricated data

What Mike Pence has said that could be used in a Donald Trump trial

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

In 'major milestone,' FDA approves first cell therapy for solid tumors

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Wikipedia

focus

knowledge

entertainment